Generex Biotechnology Corporation (OTCMKTS: GNBT) is making a strong move up the charts after the Company closed a $50 million Licensing and Development Agreement...
Generex Biotechnology Corporation (OTCMKTS: GNBT) is an exciting biotech trading at the bottom of its range that has a promising COVID-19 Vaccine using li-key...
Generex Biotechnology Corporation (OTCMKTS: GNBT) was on the rise again as the rest of the markets dropped after the Company announced they have recieved...
Generex Biotechnology Corporation (OTCMKTS:GNBT) has seen a significant rise in recent days after the Company reported the successful completion of the FINRA review process...
Generex Biotechnology Corporation (OTCMKTS:GNBT) has continued to move lower in recent months continuing a trend that has lasted for years. The stock seems to...
